| Formulary Chapter 4: Central nervous system - Full Chapter
|
| 04.07.04.01 |
Treatment of the acute migraine attack |
|
|
| 04.07.04.01 |
5HT1 agonists |
|
|
Sumatriptan (Imigran Subject®)
(pre-filled cartridge syringes for injection)
|
Formulary
|
For migraine if oral or nasal preparations fail, or for cluster headache.
6mg/0.5ml pre-filled syringes in a cartridge pack for use in conjunction with an auto injector for subcutaneous injection.
Note: sumatriptan injection as pre-filled pens (Sun Pharmaceuticals) are non-formulary (see below).
|
Eletriptan (Relpax®)
(tablets)
|
Non Formulary
|
|
Rizatriptan
(tablets/orodispersible tablets)
|
Non Formulary
|
|
Sumatriptan
(pre-filled disposable pens for injection)
|
Non Formulary
|
Not currently supported for use locally (Imigran Subject brand is formulary choice).
3mg/0.5ml; 6mg/0.5ml |
Sumatriptan (Imigran Radis®)
(dispersible tablets)
|
Non Formulary
|
|
Zolmitriptan
(tablets/orodispersible tablets)
|
Non Formulary
|
|
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Traffic Light Status Information
| Status |
Description |
|
Suitable for prescribing by all in both primary and secondary care. |
|
Specialist recommended but suitable for continuation in primary care. |
|
Specialist initiated but suitable for continuation in primary care. |
|
Specialist initiated and for continuation in primary care under a locally approved shared care guideline. |
|
Suitable for prescribing in specialist settings (secondary care) only. |
|
Secondary care medicines to be used under specialised commissioning arrangements only. |
|
For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital
pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy. |
|
Not recommended for use. |
|
|
